Picton Mahoney Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Picton Mahoney Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-175,000	Closed	-$8.22M	–	1203
2025 Q2	$8.22M	Buy	+175,000	New	+$7.79M	0.08%	213

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Picton Mahoney Asset Management's SWTX Position: Q3 2025 in Review

Picton Mahoney Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 175,000 shares — an estimated $8.22M sold.

Picton Mahoney Asset Management first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $8.22M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Picton Mahoney Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Picton Mahoney Asset Management sold 175,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $8.22M.
Picton Mahoney Asset Management first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Picton Mahoney Asset Management's SpringWorks Therapeutics position peaked at $8.22M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.